Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outpatient balloon catheter versus expectant management for post-term labor induction in nulliparous women: A randomized trial.

Journal of gynecology obstetrics and human reproduction·2024

Same author

Development of placental lesions after recovery from COVID-19 during pregnancy: case-control study.

BJOG : an international journal of obstetrics and gynaecology·2023

Same author

[Are gestational weight gain guidelines for obese women still appropriate?]

Gynecologie, obstetrique, fertilite & senologie·2022

Same author

[Medical strategy for abortions between 14 and 16 weeks of gestation].

Gynecologie, obstetrique, fertilite & senologie·2022

Same author

[Expert consensus from the College of French Gynecologists and Obstetricians: Management of nausea and vomiting of pregnancy and hyperemesis gravidarum].

Gynecologie, obstetrique, fertilite & senologie·2022

Same author

[SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].

Gynecologie, obstetrique, fertilite & senologie·2022

Same journal

[How I do… to see the sliding sign by transvaginal ultrasonography?]

Gynecologie, obstetrique & fertilite·2016

Same journal

[Cell-free fetal DNA screening tests for trisomy 21].

Gynecologie, obstetrique & fertilite·2016

Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016

Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016

Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016

Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

[Obesity and pregnancy].

¹Pôle mère, enfant, nouveau-né, maternité Jeanne-de-Flandre, CHRU de Lille, 1, rue Eugène-Avinée, 59037 Lille cedex, France. philippe.deruelle@chru-lille.fr

Gynecologie, Obstetrique & Fertilite

|February 15, 2011

Summary

This summary is machine-generated.

Pregnancy obesity raises risks for mothers and newborns, complicating deliveries. Specialized perinatal care organization can improve management for obese pregnant women, particularly those with morbid obesity.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Swimming Exercise Protocol and Care Methods for Pregnant Rats

Swimming Exercise Protocol and Care Methods for Pregnant Rats

Published on: April 5, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Swimming Exercise Protocol and Care Methods for Pregnant Rats

Swimming Exercise Protocol and Care Methods for Pregnant Rats

Published on: April 5, 2024

Area of Science:

Obstetrics and Gynecology
Maternal-Fetal Medicine
Public Health

Context:

Pregnancy obesity is a significant risk factor for adverse maternal and neonatal outcomes.
Increased rates of gestational hypertension, diabetes mellitus, and difficult deliveries (e.g., cesarean sections) are associated with maternal obesity.
Peridural analgesia failure is also more common in obese pregnant individuals.

Purpose:

To highlight the increased risks associated with obesity during pregnancy.
To underscore the delivery complications linked to maternal obesity.
To advocate for improved management strategies for pregnant women with obesity, especially morbid obesity, through specialized perinatal networks.

Summary:

Obesity in pregnancy elevates risks for maternal conditions like gestational hypertension and diabetes mellitus.
Newborns of obese mothers face higher incidences of malformations and macrosomia.
Pregnancy-related obesity complicates labor and delivery, increasing cesarean section rates and peridural analgesia challenges.

Impact:

Implementing organized perinatal care networks can enhance the management of pregnant women with obesity.
Improved management can potentially mitigate maternal and neonatal complications.
Specialized care is crucial for addressing the unique challenges of morbid obesity in pregnancy.